388870 — Pharos IBio Co Balance Sheet
0.000.00%
- KR₩147bn
- KR₩125bn
Annual balance sheet for Pharos IBio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|
Period Length: | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Cash | |||
Cash and Equivalents | |||
Short Term Investments | |||
Cash and Short Term Investments | 23,812 | 15,079 | 25,487 |
Net Total Accounts Receivable | |||
Net Total Receivables | 67.4 | 225 | 280 |
Prepaid Expenses | |||
Total Current Assets | 24,422 | 15,715 | 26,170 |
Gross Property, Plant And Equipment | |||
Accumulated Depreciation | |||
Net Property, Plant And Equipment | 2,700 | 2,541 | 3,218 |
Net Intangible Assets | |||
Long Term Investments | |||
Other Long Term Assets | |||
Total Assets | 27,486 | 18,721 | 29,690 |
Payable / Accrued | |||
Accrued Expenses | |||
Notes Payable / Short Term Debt | |||
Current Portion of Long Term Debt / Capital Leases | |||
Total Other Current Liabilities | |||
Total Current Liabilities | 78,088 | 951 | 1,213 |
Long Term Debt | |||
Capital Lease Obligations | |||
Total Long Term Debt | |||
Total Debt | |||
Total Other Liabilities | |||
Total Funded Status | |||
Total Liabilities | 78,670 | 1,056 | 1,341 |
Common Stock | |||
Additional Paid In Capital | |||
Retained Earnings (Accumulated Deficit) | |||
Other Equity | |||
Total Equity | -51,184 | 17,665 | 28,349 |
Total Liabilities & Shareholders' Equity | 27,486 | 18,721 | 29,690 |
Total Common Shares Outstanding |